Novavax licenses Matrix-M adjuvant to Pfizer in deal worth up to $530 million By Investing.com Company News Published 01/20/2026, 07:21 AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results